The Rise of the Longevity Family Office

Fall 2025 Capital Deployment: A Defining Moment for Longevity Investment

The Billionaires Fueling the Quest for Longer Life

The Growing Femtech Longevity Market: Opportunities in Menopause and Reproductive Health for Investors

Julius Baer Report: High-Net-Worth Individuals Are Redefining Priorities

13 anti-aging startups on a mission to extend live

Behind the billionaire-backed longevity business — and the innovations that could help us live longer

M42 makes strategic investment in Juvenescence and forms partnership to develop therapeutics for age-related diseases

Bitcoin, Tech and Crypto Meets Longevity: Capital’s Shared Bet on Time

The tech billionaires trying to hack aging to extend their lives

Human Longevity Taps Alamar Biosciences to Power Proteomic Innovation in Longevity Research

Inside the longevity fund that aims to ‘make death optional’

Omega raises $647M for 8th fund aimed at innovative biotechs

Innovations in longevity research and therapeutics in 2024

VC releases in-depth analysis of leading companies in LongBio sector

Aeovian nabs $55M to fund mid-stage epilepsy study

LongeVC's Sergey Jakimov sees opportunity in NIH cuts

An Investor's Guide to the Global Longevity Market

VCs Haven’t Tired Of Sleep Startups

What to Expect from Healthcare Investments in 2025

Top Longevity Investors Globally by Number of Investments

NewLimit, founded by Coinbase CEO Brian Armstrong, raises $130M to develop age-reversing treatments